ADAR1 Capital Management »

Igm Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Igm Biosciences (IGMS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Igm Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Igm Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Igm Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $39k 4.0k 9.65

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Igm Biosciences

Baker Bros. Advisors
T. Rowe Price Associates
Siren
Redmile Group
Goldman Sachs Group
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Invesco
Northern Trust
TD Asset Management
Charles Schwab Investment Management
Morgan Stanley

View all funds holding Igm Biosciences